NYSEMKT: APUSApimeds Pharmaceuticals Us Inc Stock Ownership - Who owns Apimeds Pharmaceuticals Us?
Insider buying vs selling
Have Apimeds Pharmaceuticals Us Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when APUS insiders and whales buy or sell their stock.
APUS Shareholders
What type of owners hold Apimeds Pharmaceuticals Us Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Inscobee Inc | 384.41% | 5,801,234 | $26.86M | Insider |
| Erik C. Emerson | 49.70% | 750,000 | $3.47M | Insider |
| Jakap Koo | 42.67% | 643,885 | $2.98M | Insider |
| Christopher Kim | 18.39% | 277,500 | $1.28M | Insider |
| Hemenway Trust Co LLC | 18.16% | 274,000 | $1.27M | Institution |
| Vanguard Capital Management LLC | 6.36% | 95,929 | $444.15k | Institution |
| Geode Capital Management LLC | 2.65% | 40,051 | $185.44k | Institution |
| Vanguard Fiduciary Trust Co | 1.59% | 24,039 | $111.30k | Institution |
| Two Sigma Securities LLC | 0.70% | 10,550 | $48.85k | Institution |
| Ubs Group Ag | 0.28% | 4,187 | $19.39k | Institution |
APUS vs Pharmaceutical Stocks
Apimeds Pharmaceuticals Us Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.